Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Remdesivir, an antiviral medication originally developed for Ebola, is now primarily indicated for hospitalized patients with COVID-19 requiring supplemental oxygen. While early clinical data suggested potential benefits, large-scale studies—including the ... Read More
Continuous Coverage
Prime Minister Shehbaz Sharif has vowed a decisive crackdown on militant factions following violence in Balochistan that claimed…
Polycythemia vera (PV) patients who fail hydroxyurea therapy face a high risk of disease progression and thrombotic complications.…
France’s Tactical Resilience Meets Officiating Noise in Morocco Quarter-Final France enters tonight’s World Cup quarter-final against Morocco under…
The Archive of an Enigma: Why Martin Margiela’s Sell-Off Defines the New Luxury Economy The fashion world is…
While the origin of the projectile remains a subject of intense geopolitical scrutiny, the incident has prompted heightened…
A breakthrough in malaria research, recently published in the journal Nature, has overturned the long-standing model of how…
Global Affairs
South Korean volleyball club Woori Card has officially signed Iranian national team middle blocker Martin Ahmadi under the…
Markets And Money
Centrale Danone, the Moroccan subsidiary of Danone S.A. (EPA: BN), has implemented a series of price hikes across…
Digital Culture
WhatsApp users can reclaim over 5 GB of local storage by utilizing the native “Storage Management” tool, which…
Science And Wellbeing
As the United Kingdom enters its third heatwave of the year, record-breaking temperatures across Western Europe have sparked…
Screen And Sound
Adriano Celentano’s 1981 classic Innamorato pazzo, starring alongside Ornella Muti, serves as a definitive case study in star-driven…
Fixtures And Form
Iman Wahid Seif Funeral Arrangements Confirmed for Saturday at Sheikh Zayed Police Mosque The family of the late…
